Molecular Mechanisms of Cytoskeletal Regulation by FMRP

With a 2-year, $120,000 grant from FRAXA Research Foundation in 2015, Dr. Samie Jaffrey from Weill Medical College of Cornell University will research the connection between FMR1, RhoA, and dendritic spine abnormalities.

$120,000 Grant

Samie Jaffrey, PhD
Principal Investigator

Cornell University
2015 FRAXA Research Grant
$120,000 over 2 Years

One feature of neurons that display abnormalities in FMR1 is that dendritic spines have abnormal shapes. This suggests that FMR1 has a role in controlling the shapes of these spines. Since spines are key structures involved in learning, memory, and behavior, the abnormal structure of these spines may explain some of the features seen in patients with Fragile X. What is unclear is how FMR1, which is known to regulate mRNA translation, controls the underlying cytoskeleton of dendritic spines.

We are investigating how FMR1 regulates an mRNA that encodes a critical regulator of the neuronal cytoskeleton called RhoA. RhoA has independently been shown to affect dendritic structure and its mRNA has been shown to interact with FMR1, thus suggesting an appealing connection between FMR1, RhoA, and spine abnormalities. If spine abnormalities are due to the inability of FMR1 to regulate RhoA, pharmacotherapy directed against RhoA or the RhoA molecular pathway may be suitable for reversing the symptoms of Fragile X.

Explore Current Fragile X Research

FRAXA-funded researchers around the world are leading the way towards effective treatments and ultimately a cure.